Navigation Links
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
Date:8/6/2008

32,532 28,480 31,879 26,175

Alexza Pharmaceuticals, Inc.

(a development stage enterprise)

Condensed Consolidated Balance Sheets

(in thousands)

June 30, December 31,

2008 2007

Unaudited (1)

Assets

Cash, cash equivalents and marketable

securities $64,005 $69,391

Investments held by Symphony Allegro, Inc. 31,310 39,449

Other current assets 996 13,432

Total current assets 96,311 122,272

Property and equipment, net 25,302 26,156

Other non-current assets 666 697

Total assets $122,279 $149,125

Liabilities, noncontrolling interest

and stockholders' equity

Current liabilities $16,453 $16,180

Non-current liabilities 30,826 33,002

Noncontrolling interest in Symphony

Allegro, Inc. 14,304 23,952

Stockholders equity 60,696 75,991

Total liabilities, non controlling

interest and stockholders' equity $122,279 $149,125

(1) Derived from audited consolidated financial statements at that date.


'/>"/>
SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2008).... 15 /- Globus Medical, Inc., the lar... the world, today announced,that the first FLEXUS(... an,Investigational Device Exemption ("IDE") recen... Dr. Rhett Murray., The FLEXUS(TM) Spacer is plac...processes with minimal disruption to the surroundi...
(Date:8/14/2008)...Aug. 14 /- Pharmasset, Inc.... company committed to,discovering, developing and ...ons, reported unaudited financial results for the ...et reported a net loss attributable to,common stoc...$0.69 for the,quarter ended June 30, 2008, as comp...
(Date:8/14/2008)... Technology Evaluated to Enable Targeting and Incr...quencing, LEXINGTON, Mass. and HEIDELBERG, German...onal Genomics Research Institute (TGen) today anno...en will evaluate,Next-Generation-Sequencing equipm...(R) Microarray Technology., febit,s HybSelect(TM)...
(Date:8/13/2008).../- As biotechnology,pharma... move clinical,trials beyond their own borders to ...rope and South America, complicated regulatory env...iness, according to an analysis by,Aon Corporation...p provides,those companies a visual representation...
Breaking Medicine Technology:First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4IAVI and VaxDesign partner to develop a clinical trial in a test tube for AIDS vaccines 13218 1IAVI and VaxDesign partner to develop a clinical trial in a test tube for AIDS vaccines 13218 2U of M finds teens who eat breakfast daily eat healthier diets than those who skip breakfast 2375 1U of M finds teens who eat breakfast daily eat healthier diets than those who skip breakfast 2375 2Adult stem cell changes underlie rare genetic disease associated with accelerated aging 13211 1Adult stem cell changes underlie rare genetic disease associated with accelerated aging 13211 2CVS Caremark All Kids Can Program Announces the Opening of a Boundless 28TM 29 Playground in Dallas to Serve Children of all Abilities 13206 1CVS Caremark All Kids Can Program Announces the Opening of a Boundless 28TM 29 Playground in Dallas to Serve Children of all Abilities 13206 2CVS Caremark All Kids Can Program Announces the Opening of a Boundless 28TM 29 Playground in Dallas to Serve Children of all Abilities 13206 3
(Date:8/20/2008)...WTON, Mass., Aug. 20 /PRNewswire/ -- Questex Media...siness media company and owner of,American Spa and... the,International Beauty Shows, the International...d the SPATEC appointment events today announced th... portals SpaTrade (, http://www.SpaTrade.com ) an...
(Date:8/20/2008)...r in secondary life insurance market ranked 156 am...in America on Inc. 500 list, BETHESDA, Md., Aug. ...der in the secondary life insurance market, announ...growing insurance related company in the US by,Inc... 2008 Inc. 500 list of,fastest growing companies i...
(Date:8/20/2008)...UTHFIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/... Wellness Promotion will give thousands of,Detroit..."HEALTHY LIVING,FOR KIDS" program. This year the p...0 a.m. to 5 p.m. at the Charles H. Wright Museum o... 1977, "Healthy Living for Kids",has provided free...
(Date:8/20/2008)...LWAUKEE, Aug. 20 /PRNewswire/ -- Fourteen physicia...p have announced that they plan to enhance,the car...ining Aurora,Health Care., "These are top-notch p...have decided to join our organization," said Nick ...ve officer. "We look forward to working with,them ...
Breaking Medicine News(10 mins):Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2
...t sexual health campaign is targeting young adults... Their focus is mainly on 18 to 24-year-olds. //Cu...eported to carry condoms on a night out. The ?4m ...exually transmitted infections like chlamydia that...
...have captured the imagination of the world as a 'r...or cajoled into restoring or rejuvenating debilita...UK scientists have helped to reiterate this belief...fered from conditions that eventually would damage...
...een popular world over for its quality poultry pro... soared to a record 3.26 Billion Rupees. //However... a worldwide epidemic brought the poultry revenues...re 3.26 billion rupees last financial year ended u...
...veterinarians in India have initiated a unique pro...to captive elephants through mobile clinics. // C... guidance of Jacob V. Cheeran, the project is supp...Nature Conservation Foundation (ANCF) and Compassi...
Other Medicine News:Health News:Risk-Taking Young Urged To Carry Condoms 2Health News:Research 'Extraordinaire' To Restore Vision 2Health News:India Free From Bird Flu 2Health News:Free health check-ups for captive elephants 2
...r is a multi-lumen, over-the-wire thrombectomy cat...al of fresh, soft thrombus in dialysis shunts. The...y alternative to surgery and thrombolytic therapy....jector. Fragments and removes thrombus to help re...
Introduced more than 30 years ago by Dr. Thomas J. Fogarty, these embolectomy catheters are indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
...tomy catheter is designed to offer the ultimate in...eate a low pressure zone around the catheter tip c... catheter, where it is fragmented by the jets, and...vides rapid restoration of flow in minutes, as opp...
When combined with a stimulation lead system, the Model 3077 SSI Temporary Pacemaker can be used whenever temporary atrial or ventricular pacing is indicated. The device can be employed for therapeut
Medicine Products: